Prevalence of metabolic syndrome in young patients with acute MI: Does the Framingham Risk Score underestimate cardiovascular risk in this population?

Diabetes and Vascular Disease Research

Volumn 3, Issue 2, 2006, Pages 103-107

  Zarich, Stuart ^a,b   Luciano, Carlo ^c   Hulford, Jackie ^c   Abdullah, Arif ^c  

^a Section of Cardiovascular Medicine   (United States)

^b BRIDGEPORT HOSPITAL   (United States)

^c NONE

Author keywords

Cardiovascular risk; Metabolic syndrome; Myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION; PREVALENCE; SCORING SYSTEM;

ACUTE DISEASE; ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL; CONNECTICUT; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; OVERWEIGHT; PREVALENCE; RISK FACTORS;

EID: 33750391890     PISSN: 14791641     EISSN: None     Source Type: Journal    
DOI: 10.3132/dvdr.2006.012     Document Type: Article

References (25)

1. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-14.
2. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
3. Sattar N, Caw A, Scherbakova O et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-19.
4. Reilly MR Wolfe ML, Rhodes T et al. Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation 2004;110:803-09.
5. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among US adults. JAMA 2002;287:356-9.
6. Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
7. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Diabetes Care 2005;28:2289-305.
8. Akosah KO, Gower E, Croon L, Rooney BL, Schaper A. Mild hypercholesterolemia and premature heart disease: Do the national criteria underestimate disease risk? J Am Coll Cardiol 2000;35:1178-84.
9. Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: How do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol 2003;41:1475-9.
10. Wilson PW, D'Agnostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
11. Girman CJ, Rhodes T, Mercuri M et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 2004;93:136-41.
12. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003;108:1541-5.
13. Greenland P, Knoll MD, Stamler J et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003;290:891-7.
14. Norhammar A, Tenerz A, Nilsson C et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359:2140-4.
15. Kowalska I, Prokop J, Cachorzewska-Galewska H et al. Disturbances of glucose metabolism in men referred for coronary arteriography. Diabetes Care 2001;24:897-901.
16. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
17. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003;107:391-7.
18. Volpato S, Palmieri E, Fellin R, Zuliani G. Acute phase markers are associated with reduced plasma lipid levels in a population of hospitalized elderly patients. Gerontology 2000;46:22-7.
19. McGill HC, McMahan A, Herderick EE et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-18.
20. Lamarche B, Moorjani S, Lupien PHJ et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Quebec cardiovascular study. Circulation 1996;94:273-8.
21. Wilson PAW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
22. Assmann C, Sculte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988;116:1713-24.
23. Dekker JM, Girman C, Rhodes T et al. Metabolic syndrome and 10 year cardiovascular disease risk in the Hoorn Study. Circulation 2005;112:666-73.
24. Grundy SM, Cleeman JI, Bairey-Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004;110:227-39.
25. Ridker PM, Cook N. Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program. Circulation 2005;111:657-8.